Immunohistochemistry (IHC) demonstrated that 65% of normal ovary and 72% of the fallopian tube tissue versus 18% of the primary and 27% of the metastatic tumor samples showed moderate to strong epithelial MARCKS immunostaining, whereas 68% of the primary and 95% of the metastatic tumor sample versus 14% of the normal ovary and 32% of the fallopian tube tissues showed moderate to strong stromal MARCKS immunostaining. Here, MARCKS is linked to metastatic neoplasm.